Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever

Int J Antimicrob Agents. 2005 Dec:26 Suppl 2:S128-32; discussion S133-40. doi: 10.1016/j.ijantimicag.2005.08.007. Epub 2005 Oct 25.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / drug therapy
  • Bacterial Infections / etiology
  • Bacterial Infections / microbiology
  • Drug Therapy, Combination
  • Fever of Unknown Origin / complications*
  • Fever of Unknown Origin / drug therapy*
  • Guidelines as Topic / standards*
  • Humans
  • Neoplasms / complications*
  • Neutropenia / complications*
  • Neutropenia / drug therapy*
  • Risk Factors
  • Treatment Outcome
  • beta-Lactamase Inhibitors
  • beta-Lactamases / therapeutic use
  • beta-Lactams / therapeutic use

Substances

  • Anti-Bacterial Agents
  • beta-Lactamase Inhibitors
  • beta-Lactams
  • beta-Lactamases